Loading clinical trials...
Loading clinical trials...
A Phase II Study of the Anti-GITR Agonist INCAGN1876 and the PD-1 Inhibitor INCMGA00012 in Combination With Stereotactic Radiosurgery in Recurrent Glioblastoma
Conditions
Interventions
INCMGA00012
INCAGN01876
+2 more
Locations
1
United States
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
Start Date
June 23, 2020
Primary Completion Date
September 8, 2022
Completion Date
April 30, 2029
Last Updated
August 15, 2025
NCT05969860
NCT02800486
NCT05789394
NCT06934889
NCT00083512
NCT05283330
Lead Sponsor
University of Pennsylvania
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions